These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 7749499)

  • 1. Autoimmunity and thyroid function in patients with chronic active hepatitis treated with recombinant interferon alpha-2a.
    Preziati D; La Rosa L; Covini G; Marcelli R; Rescalli S; Persani L; Del Ninno E; Meroni PL; Colombo M; Beck-Peccoz P
    Eur J Endocrinol; 1995 May; 132(5):587-93. PubMed ID: 7749499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thyroid autoimmune disorders in patients with chronic hepatitis C before and during interferon-alpha therapy.
    Marazuela M; García-Buey L; González-Fernández B; García-Monzón C; Arranz A; Borque MJ; Moreno-Otero R
    Clin Endocrinol (Oxf); 1996 Jun; 44(6):635-42. PubMed ID: 8759175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of thyroid autoimmunity after administration of recombinant human interferon-alpha 2b for chronic viral hepatitis.
    Chung YH; Shong YK
    Am J Gastroenterol; 1993 Feb; 88(2):244-7. PubMed ID: 8424429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Temporal relationship between the appearance of thyroid autoantibodies and development of destructive thyroiditis in patients undergoing treatment with two different type-1 interferons for HCV-related chronic hepatitis: a prospective study.
    Mazziotti G; Sorvillo F; Stornaiuolo G; Rotondi M; Morisco F; Ruberto M; Cioffi M; Amato G; Caporaso N; Gaeta GB; Carella C
    J Endocrinol Invest; 2002; 25(7):624-30. PubMed ID: 12150338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased risk of autoimmune thyroid disease in hepatitis C vs hepatitis B before, during, and after discontinuing interferon therapy.
    Fernandez-Soto L; Gonzalez A; Escobar-Jimenez F; Vazquez R; Ocete E; Olea N; Salmeron J
    Arch Intern Med; 1998 Jul; 158(13):1445-8. PubMed ID: 9665354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective study on thyroid autoimmunity and dysfunction related to chronic hepatitis C and interferon therapy.
    Custro N; Montalto G; Scafidi V; Soresi M; Gallo S; Tripi S; Notarbartolo A
    J Endocrinol Invest; 1997; 20(7):374-80. PubMed ID: 9309534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Virologic factors related to interferon-alpha-induced thyroid dysfunction in patients with chronic hepatitis C.
    Hsieh MC; Yu ML; Chuang WL; Shin SJ; Dai CY; Chen SC; Lin ZY; Hsieh MY; Liu JF; Wang LY; Chang WY
    Eur J Endocrinol; 2000 May; 142(5):431-7. PubMed ID: 10802518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple changes in thyroid function in patients with chronic active HCV hepatitis treated with recombinant interferon-alpha.
    Roti E; Minelli R; Giuberti T; Marchelli S; Schianchi C; Gardini E; Salvi M; Fiaccadori F; Ugolotti G; Neri TM; Braverman LE
    Am J Med; 1996 Nov; 101(5):482-7. PubMed ID: 8948271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hepatitis C virus infection and thyroid diseases].
    Broussolle C; Steineur MP; Bailly F; Zoulim F; Trépo C
    Rev Med Interne; 1999 Sep; 20(9):766-73. PubMed ID: 10522298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoantibodies during alpha-interferon therapy for chronic hepatitis B.
    Fattovich G; Betterle C; Brollo L; Pedini B; Giustina G; Realdi G; Alberti A; Ruol A
    J Med Virol; 1991 Jun; 34(2):132-5. PubMed ID: 1890413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Organ-specific autoimmunity and genetic predisposition in interferon-treated HCV-related chronic hepatitis patients.
    Floreani A; Chiaramonte M; Greggio NA; Fabris P; De Lazzari F; Naccarato R; Betterle C
    Ital J Gastroenterol Hepatol; 1998 Feb; 30(1):71-6. PubMed ID: 9615270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significance of anti-interferon-alpha2 and sICAM-1 activities in the sera of viral hepatitis B and C patients treated with human recombinant interferon-alpha2.
    Stancek D; Fuchsberger N; Oltman M; Schmeisser H; Kontsek P; Jahnová E; Hajnická V
    Acta Virol; 2001; 45(5-6):287-92. PubMed ID: 12083327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of the prevalence of autoantibodies in individuals with chronic hepatitis C and those with autoimmune hepatitis: the role of interferon in the development of autoimmune diseases.
    Bayraktar Y; Bayraktar M; Gurakar A; Hassanein TI; Van Thiel DH
    Hepatogastroenterology; 1997; 44(14):417-25. PubMed ID: 9164512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serological markers of autoimmunity in renal transplant patients before and after alpha-interferon therapy for chronic hepatitis C.
    Rostaing L; Oksman F; Izopet J; Baron E; Cisterne JM; Hoff M; Abbal M; Durand D
    Am J Nephrol; 1996; 16(6):478-83. PubMed ID: 8955758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term outcome of interferon-alpha-induced thyroid autoimmunity and prognostic influence of thyroid autoantibody pattern at the end of treatment.
    Carella C; Mazziotti G; Morisco F; Manganella G; Rotondi M; Tuccillo C; Sorvillo F; Caporaso N; Amato G
    J Clin Endocrinol Metab; 2001 May; 86(5):1925-9. PubMed ID: 11344186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoimmunity against pancreatic islets and other tissues before and after interferon-alpha therapy in patients with hepatitis C virus chronic infection.
    Betterle C; Fabris P; Zanchetta R; Pedini B; Tositti G; Bosi E; de Lalla F
    Diabetes Care; 2000 Aug; 23(8):1177-81. PubMed ID: 10937518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thyroid function and anti-thyroid autoantibodies in untreated children with vertically acquired chronic hepatitis C virus infection.
    Indolfi G; Stagi S; Bartolini E; Salti R; de Martino M; Azzari C; Resti M
    Clin Endocrinol (Oxf); 2008 Jan; 68(1):117-21. PubMed ID: 17692107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoimmunity during alpha-interferon therapy for chronic hepatitis C.
    Yoshikawa M; Sakamoto T; Mitoro A; Mochi T; Tsujii H; Koizumi M; Yoshiji H; Sakaguchi Y; Fukui H; Nakano H
    Gastroenterol Jpn; 1993 May; 28 Suppl 5():109-14. PubMed ID: 8359620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and significance of thyroid autoantibodies in patients with chronic hepatitis C virus infection: a prospective controlled study.
    Huang MJ; Tsai SL; Huang BY; Sheen IS; Yeh CT; Liaw YF
    Clin Endocrinol (Oxf); 1999 Apr; 50(4):503-9. PubMed ID: 10468911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autoantibodies in children with chronic hepatitis B infection and the influence of interferon alpha.
    Kansu A; Kuloğlu Z; Demirçeken F; Girgin N
    Turk J Gastroenterol; 2004 Dec; 15(4):213-8. PubMed ID: 16249973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.